Literature DB >> 1377426

Neural substrates of opiate withdrawal.

G F Koob1, R Maldonado, L Stinus.   

Abstract

Drug withdrawal is an integral part of most types of dependence and, to a large extent, opiate withdrawal has been considered the prototypic, classic measure of opiate dependence. The opiate withdrawal syndrome is characterized by multiple behavioral and physiological signs such as behavioral activation, ptosis, diarrhea, 'wet dog' shakes and motivational dysfunction, which may be represented in the CNS at multiple sites. It seems that the activating effects associated with the opiate withdrawal syndrome may be mediated by the nucleus locus coeruleus. Other signs such as wet dog shakes may involve sites in the hypothalamus important for temperature regulation. Certain other signs such as diarrhea and lacrimation may be dependent on peripheral opiate receptors. The motivational aspects of opiate withdrawal as demonstrated by the aversive stimulus effects or negative reinforcing effects (e.g. disrupted lever-pressing for food and place aversions) may involve those elements of the nucleus accumbens that are known to be important for the acute reinforcing effects of opiates in nondependent rats. Evidence exists at the cellular and molecular level for both 'within-system' and 'between-system' adaptations to dependence. Elucidation of the neural networks, cellular mechanisms and molecular elements involved in opiate withdrawal may provide not only a model for our understanding of the adaptive processes associated with drug dependence but also of those associated with other chronic insults to CNS function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377426     DOI: 10.1016/0166-2236(92)90171-4

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  92 in total

1.  Opioid receptor modulation of a metabolically sensitive ion channel in rat amygdala neurons.

Authors:  X Chen; H G Marrero; J E Freedman
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption.

Authors:  Carrie L Walters; Bao-Cheng Wang; Misty Godfrey; Duxin Sun; Colin D Funk; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

3.  How to design an opioid drug that causes reduced tolerance and dependence.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

4.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

5.  CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.

Authors:  S B Lane-Ladd; J Pineda; V A Boundy; T Pfeuffer; J Krupinski; G K Aghajanian; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

6.  Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats.

Authors:  Ning-Ning Chu; Yan-Fang Zuo; Li Meng; David Yue-Wei Lee; Ji-Sheng Han; Cai-Lian Cui
Journal:  Brain Res       Date:  2007-09-20       Impact factor: 3.252

Review 7.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

8.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

9.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

10.  Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice.

Authors:  V A Boundy; S J Gold; C J Messer; J Chen; J H Son; T H Joh; E J Nestler
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.